title: Clinical significance of recombinant interferon-alpha 2 neutralizing antibodies in hepatitis patients.
authors: Department of Biomedicine, University of Pisa, Italy.
authors: G
authors: G
authors: Antonelli
authors: G
authors: G
authors: Giannelli
authors: M
authors: M
authors: Pistello
authors: F
authors: F
authors: Maggi
authors: L
authors: L
authors: Vatteroni
authors: M
authors: M
authors: Currenti
authors: S
authors: S
authors: Del Vecchio
authors: L
authors: L
authors: Roffi
authors: G
authors: G
authors: Pastore
authors: F
authors: F
authors: Dianzani
mesh_terms: D000918:Antibody Specificity; D000937:Antigen-Antibody Reactions; D002908:Chronic Disease; D006526:Hepatitis C / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000276:immunology / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012189:Retrospective Studies
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins